脑内低度瘤与ALK重组:各种瘤类型与共享的分子变化
Kun Mu1, Yu Zhang2, Yuyu Yang3
1Department of Pathology, School of Basic Medical Sciences, Shandong University, Jinan, China; Department of Pathology, Qilu Hospital of Shandong University, Jinan, China.
Human pathology
|August 11, 2025
概括
在罕见的低度脑瘤中发现了亚纳普拉斯性淋巴瘤激酶 (ALK) 基因重组,包括炎症性肌纤维细胞瘤和膜瘤. 这些ALK融合可能是各种低度内瘤的统一特征.
科学领域:
- 神经瘤学神经瘤学
- 分子病理学分子病理学
- 癌症基因组学 癌症基因组学
背景情况:
- 在儿科高度质瘤中,日益多地发现了亚纳普拉斯性淋巴瘤激酶 (ALK) 基因融合.
- 内低度瘤与ALK重组的研究不足.
- 了解低度脑瘤中的ALK变化对于诊断和治疗至关重要.
研究的目的:
- 描述内低度瘤与ALK重组的临床病理和分子特征.
- 识别与ALK变化相关的潜在新型瘤实体.
- 为了研究ALK重组在低度脑瘤队列中的意义.
主要方法:
- 对五种低度内瘤与ALK重组的综合临床病理学评估.
- 形态分析,免疫组织化学分析 (ALK,GFAP,Olig2等等) ) 和分子特征 (DNA/RNA测序).
- 对涉及2p23.3.处ALK位点的结构染色体异常的分析.
主要成果:
- 所有五种瘤都表现出涉及ALK位点 (2p23) 的结构性异常.
- 确定的ALK融合包括SQSTM1::ALK,NPM1::ALK (在IMTs中),HNRNPA1::ALK (在基性ST-EPN中) 和PPP1CB::ALK (在GG中).
- 鉴定出了一种具有ATIC::ALK重组的新型低度状介质瘤.
结论:
- ALK重组是低度内瘤的共同特征,包括IMT,tanycytic ST-EPN,GG,以及一种新的myxoid介质细胞瘤.
- 完全切除瘤导致了良好的结果,在随访期间没有复发.
- 需要对更大的队列进行进一步的研究,以阐明ALK重新排列的低度脑瘤的临床和病理谱.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
7.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.6K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K